Cancer Screening: Theory and Practice
This useful reference provides solid knowledge of the risks and benefits associated with the cancer screening process, assesses abnormal results and therapeutic outcomes, and facilitates the communication of these issues to patients.
Describes screening tests from individual, health care, ethical, legal, and regulatory perpectives!
Gathering insights from over 35 international experts in the field, Cancer Screening
Including over 1300 references, tables, and figures, Cancer Screening is an indispensable guide for basic and clinical oncologists, internists and family practitioners, gynecologists, public health physicians, health policy specialists, health economists, health educators, prevention and early detection advocates, epidemiologists, biometricians, statisticians, and medical school and graduate students in these disciplines.
Шта други кажу - Напишите рецензију
Нисмо пронашли ниједну рецензију на уобичајеним местима.
Heroic Myths and Probability Confronting the Limits of Screening
BASIC PRINCIPLES OF SCREENING
Screening Theory and Study Design The Basics
DecisionMaking About Screening Individual and Policy Levels
Regulation of Medical Devices by the Food and Drug Administration with Emphasis on In Vitro Diagnostic Devices
Ethics and Consent
SCREENING FOR SPECIFIC CANCERS
adenocarcinoma adenomas analysis antigen asymptomatic benefit biopsy bladder cancer BRCA1 breast cancer cancer detection cancer mortality rate cancer risk case-control study cell carcinoma cervical chest radiography Clin clinical colorectal cancer control group cost diagnosis disease early detection endometrial cancer endoscopy estrogen ethical evaluation examination follow-up gastric cancer gene genetic head and neck hepatocellular carcinoma high-risk identified incidence increased risk individuals Int J Cancer invasive K-ras lesions lung cancer malignant mammography markers mass screening melanoma mutations National Cancer Institute Natl Cancer Inst neck cancer neuroblastoma occult blood ovarian cancer pancreatic cancer participants patients physicians population potential prevalence procedure prostate cancer prostate-specific antigen radiograph randomized trial reduction relative risk reported resection risk factors samples screened group screening for prostate screening program screening studies screening test second primary tumors sensitivity serum sigmoidoscopy specificity sputum cytology stage survival rate therapy treatment ultrasound Urol women aged